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Abstract
APOE plays a well established role in lipid metabolism. Animal model evidence suggests APOE may also be associated with
adiposity, but this has not been thoroughly investigated in humans. We measured adiposity (BMI, truncal fat mass, waist
circumference), physical activity (PA), cardiorespiratory fitness and APOE genotype (E2, E3, E4) in 292 8-year-old children
from the Tasmanian Infant Health Survey (TIHS), an Australian population-based prospective birth cohort. Our aims were to
examine the association of APOE with child adiposity, and to examine the interplay between this association and other
measured factors. We found that APOE was associated with child lipid profiles. APOE was also associated with child adiposity
measures. The association was E4 allele-specific, with adiposity lower in the E4-containing group (BMI: Mean difference
-0.90 kg/m2; 95% confidence intervals (CI) -1.51, -0.28; p = 0.004). The association of APOE4 with lower BMI differed by fitness
status (difference in effect p = 0.002), and was more evident among the less fit (mean difference -1.78 kg/m2; 95% CI -2.74,
-0.83; p,0.001). Additionally, associations between BMI and lipids were only apparent in those of lower fitness who did not
carry APOE4. Similar overall findings were observed when truncal fat mass and waist circumference were used as alternative
adiposity measures. APOE4 and cardiorespitatory fitness could interact to influence child adiposity. In studies addressing the
genetic determinants of childhood obesity, the context of child fitness should also be taken into account.
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Introduction
The plasma protein apolipoprotein E (apoE), encoded by the
gene APOE, plays an important role in lipid metabolism. ApoE
carries lipids in the bloodstream, and mediates the influx of lipids
into cells such as adipocytes [1]. There are three isoforms; e2, e3
and e4, encoded by three alleles, E2, E3, and E4. The isoforms
differ in their binding affinities for lipids and lipoprotein receptors
[2].
There is a well-established relationship between serum LDL
cholesterol (LDL-C) and genotypes of APOE in adults and in
children. The relationship is approximately linear, with E2
associated with the lowest, and E4 associated with the highest,
LDL-C, as demonstrated by Bennet and colleagues by meta-
analysis [2]. For children specifically, equivalent relationships
between APOE genotype and LDL-C have also been repeatedly
demonstrated [3,4,5,6,7].
The determination of body mass index (BMI) and the
development of obesity are thought to be controlled, at least in
part, by the regulation of lipid flux by adipose tissue [1]. Adipose
tissue serves as a storage site for triglycerides (TGs) derived from
lipoproteins delivered by the circulation. ApoE is highly expressed
in adipocytes, and rodent apoe knockouts (EKO) show smaller
adipocytes containing significantly less TG compared to wildtype.
Whilst circulating apoE has been shown to also play a role,
transplantation of EKO adipocytes into wildtype animals has
demonstrated the importance of endogenous apoE in determining
adipocyte size and TG content [1,8].
There is evidence to suggest that the ability to store TGs may
differ between human apoE isoforms. When fed a ‘Western-style’
high-fat diet for eight weeks, knock-in mice containing human
APOE3 gained 30% more weight than APOE4 knock-ins [9]. Thus,
human APOE genotype may be important in determining
adiposity.
One adult study investigating APOE with lipids and coronary
risk suggested that there may be an association between APOE
genotype and BMI, with E4 carriers having a (non-significantly)
lower BMI than E3/E3 or E2 carriers in both whites and African
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Americans [10]. However, recent large scale genome-wide
association analyses [11] have not detected an association of
APOE genotype with human adiposity. Little data has been
available for children, however, it might be argued that child
studies may provide a clearer picture due to a lack of confounding
by co-morbidities and resultant medication.
Further, effect modification of the APOE-BMI association will
be important to consider. A recent study examining interaction
between obesity-associated genes and physical activity in Europe-
an adults indicated that genetic predisposition to obesity is
significantly attenuated by a physically active lifestyle [12]. Studies
including The Cardiovascular Risk in Young Finns Study have
demonstrated that physical activity (PA) appears to act as an effect
modifier on the relationship between APOE genotype and serum
lipids [7,13]. Thus, given that PA, and also cardiorespiratory
fitness (CRF), have obvious effects on energy balance, we
hypothesised that PA and/or CRF might also modify any effect
of APOE on adiposity. We therefore explored the relationship
between APOE genotype, lipids, PA, CRF, and measures of
adiposity, using relevant data available from participants of the
Tasmanian Infant Health Survey (TIHS), a prospective birth
cohort study.
Materials and Methods
Ethics Statement
The Human Research Ethics Committee (University of
Tasmania) approved each stage of the study. Parental written
consent and child verbal assent was obtained.
Study sample
Singleton participants in the TIHS born in 1989 who had
participated in a follow-up study in Southern Tasmania at age 7–8
years [14,15] and were still residing in the South of the State (a
defined geographical region based on telephone code) in 2002,
were eligible for this study.
During the years 1988-1995, 10,562 newly-born infants were
recruited into the TIHS, which had been established to investigate
sudden infant death syndrome (SIDS) [16]. The selection of
eligible singleton subjects was based on SIDS risk factors as
described previously [17]. Parents of 1182 of the surviving infants
among 1256 eligible singletons who were born specifically in 1989
participated in an in-hospital interview. In 1997, 538 of these
children (now 8 years of age) who were deemed eligible for a
cholesterol study were identified at schools in southern Tasmania
and invited to participate; 388 did so. Detailed anthropometric
measures and fasting blood samples for lipid analysis and
measurement of glucose and insulin were collected [14,15]. In
2002, 353 of these were traced to an address in southern Tasmania
and 339 agreed to participate in a further study investigating
genetic factors. Of these, 292 previously had skin folds and serum
insulin measured at 8 years of age in 1997, and these children
formed the sample for this and previous gene-environment studies
[18].
Measurements
Children underwent measurements of anthropometry and had a
fasting blood sample taken. Weight was measured in light clothing
using scales that were calibrated daily. Height was measured in
bare feet using a stadiometer. BMI was calculated as the ratio of
weight to squared height. Waist circumference was measured.
Skin-fold thickness was measured with callipers at the mid-
abdominal, subscapular, and suprailiac sites, with triplicate
measures taken at each site and averaged. Truncal fat mass was
calculated as the mean skin-fold thickness from these three sites.
Blood samples were analysed by a laboratory accredited by
National Association of Testing Authorities and participating in
Royal College of Pathologists of Australasia/Australasian Associ-
ation of Clinical Biochemists external quality assurance pro-
grammes. The Vitros analyser was used for biochemical estimation
of serum TG (Ortho Clinical Diagnostics). Child physical activity
(PA) was measured by pedometer over one school lunchtime. The
number of recorded steps was adjusted for the length of time the
pedometer was worn. PA was also recorded via parent-reported
usual activity during lunchtime [15]. Reported activities were
categorised into low-moderate (sit/talk, read/study, walk, use play
equipment) or high (run, sports training) activity levels for the
purposes of analysis. Child CRF was assessed by the 20 metre
endurance multistage shuttle run test. This test required children
to run back and forth between two lines set 20 m apart with a
protocol of increasing velocity and scoring by laps completed at
various shuttle run velocity levels [19]. This test has been validated
as a measure of aerobic fitness in children [20].
DNA collection, extraction and genotyping
Buccal mucosa swabs were collected with Gentra PureGene
brushes and DNA extracted using PureGene DNA Isolation Kits
(Gentra Systems, MN, USA). The two nucleotide substitutions, a
C to T at codon 112 (Cys112Arg, rs429358) and a C to T at codon
158 (Cys158Arg, rs7412) in APOE that encode the E2, E3 and E4
alleles were detected as described previously [18].
Data analysis
Data were described using means and standard deviations or
medians and inter-quartile ranges. The distribution of TG was
right skewed and was log-transformed prior to analysis. Charac-
teristics of the participants were compared between APOE groups
using analysis of variance and chi-squared tests.
Consistent with a number of previous studies [2], APOE
genotypes were grouped into three categories according to E2
and E4 carrier status: E2 carriers (E2/E2, E2/E3), E4 carriers
(E4/E4, E4/E3), and reference (E3/E3). Individuals carrying E2/
E4 (n= 7) were excluded from this classification. We then
dichotomised the APOE genotypes in two ways: E4-containing
(E3/E4, E4/E4) versus not E4-containing (E2/E2, E2/E3, E3/
E3), and E2-containing (E2/E2, E2/E3) versus not E2-containing
(E4/E4, E4/E3, E3/E3) groups.
The association between BMI and APOE was investigated using
linear regression models adjusted for age and sex. Estimated
differences in mean BMI with 95% confidence intervals and Wald
test p-values are presented. Confounders of the association
between BMI and APOE were identified on the basis of whether
the estimated association changed by more than 10% when the
confounder was entered into the model. Linear regression models
of BMI on APOE further adjusted for lipids and insulin were fitted
to separate direct effects of APOE on BMI from those potentially
mediated through the lipids or insulin. Finally, sex, PA and CRF
were each considered as potential modifiers of the association
between BMI and APOE. Each potential modifier was added
singly to the regression model with a product term representing
the interaction between APOE and the potential modifier. PA and
CRF were initially included as continuous variables, then
dichotomised at the median.
The association between lipids and APOE was investigated using
linear regression models adjusted for age and sex. CRF was
considered as a potential modifier of this association, so was added
APOE, Fitness and Adiposity in Children
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to the model with an interaction term between dichotomised
fitness and APOE.
Finally, a linear regression model of BMI on lipids was fitted
within categories defined by dichotomised CRF (high fit: at or
above median, vs low fit: below median) and APOE genotype (E4-
containing vs not E4-containing), adjusted for age and sex.
P-values presented are two-sided. A p-value less than 0.05 was
considered significant. All data analyses were performed in Stata
Version 10.1 (Statacorp).
Results
APOE genotype is associated with lipid profile in the TIHS
The sample consisted of 292 children (208 boys, 84 girls) with a
mean age of 8.2 years. A total of 290 children (99.3%) were
successfully genotyped for the APOE variants. The genotype
frequencies for the two SNPs were as follows: rs429358 TT
71.7% (208/290), TC 25.9% (75/290), CC 2.4% (7/290); rs7412
TT 1.0% (3/290), TC 14.8% (43/290), TT 84.1% (244/290).
Both variants were in Hardy Weinberg Equilibrium (rs429358:
p = 0.99; rs7412: p = 0.78). Initially, APOE genotypes were
grouped into three categories according to E2 and E4 carrier
status: E2 carriers (n = 39), E4 carriers (n = 75), and E3/E3
reference (n = 169). Table 1 shows characteristics of the study
sample by APOE genotype. As expected, we found strong
evidence that APOE genotype was associated with LDL-C
(p,0.001), and to a lesser extent with HDL/Total cholesterol
ratio (HDL/Total-C) and log-transformed triglyceride (TG)
levels. Additionally, APOE genotype was associated with a
number of adiposity measures, including BMI (p = 0.01), skinfold
measures (eg suprailiac, p = 0.03), and waist circumference
(p = 0.02). No associations were detected between APOE genotype
and CRF or PA.
APOE4, but not APOE2 is associated with adiposity
Table 2 shows the characteristics of participants after dichot-
omising into E4-containing (n = 75) and not E4-containing
(n = 208) genotype groups. Of the lipid measures, only higher
LDL-C was associated with E4-containing genotype. (p = 0.03).
However, E4 was shown to be associated with reduced adiposity
(eg. E4-containing: lower BMI, p = 0.004; reduced truncal fat
mass, p = 0.02; lower waist circumference, p = 0.006).
When participants were dichotomised into E2-containing
(n = 39) and not E2-containing (n = 244) genotype groups, E2-
dichotomised APOE genotype was associated with measures of
lipids (E2-containing: lower LDL-C, p,0.001; higher HDL/
Total-C ratio, p,0.001; higher HDL-C, p= 0.02; higher TG,
p= 0.01), but there was no evidence of association of APOE2 with
adiposity.
APOE4 remains associated with BMI after adjustment for
confounders
The evidence of association between APOE4 and lower BMI
was of particular interest. To further explore this, we considered
the involvement of possible confounders. First, adjustment for age
and sex did not alter the association (Mean difference = 0.87 kg/
m2; 95% CI 0.26, 1.47; p= 0.006). A number of other variables in
the dataset that were potentially related to BMI were also
considered as confounders, including birth weight, length and
head circumference, maternal age, alcohol consumption by the
mother in pregnancy, and also CRF and lower PA in childhood.
None materially changed the association when added into the
model individually.
An investigation of whether lipids and insulin may be on
the causal pathway from APOE4 genotype to BMI
We tested the hypothesis that the association of APOE4 with
BMI may be party mediated by the relationship between APOE4
and LDL-C. We found that the magnitude of the association
between APOE4 and BMI was not reduced when adjusted for
LDL-C (Mean difference = 0.99 kg/m2; 95% CI 0.38, 1.61;
p = 0.002). APOE4 was also associated with insulin (p = 0.027);
adjustment of the APOE4 - BMI association by insulin reduced,
but did not remove, the relationship (Mean difference = 0.75 kg/
m2; 95% CI 0.15, 1.36; p = 0.015). Similar adjustments for other
lipids and glucose also did not alter the association. Therefore, the
association between APOE4 genotype and lower child BMI
appeared independent of measured metabolic profile.
Physical activity and fitness are associated, but only
fitness is associated with lipids
PA and CRF were found to be moderately associated. For
example, children with a higher lunchtime pedometer score were
more likely to complete extra laps of the shuttle test (p = 0.011). No
associations were seen between PA (pedometer or parent-report)
and lipids (adjusted for age and sex). However, higher fitness was
associated with higher HDL-C (p= 0.004), higher HDL/Total-C
ratio (p = 0.034), and lower TG (p= 0.026) (adjusted for age and
sex). Therefore fitness appeared more relevant to lipid profile than
PA in this study.
Fitness appears to modify the relationship between
APOE4 and BMI
We considered three possible effect modifiers of the APOE4 –
lower BMI association; sex, PA, and CRF. No interactions were
detected for sex (adjusted for age), or for either PA measure
(adjusted for age and sex). However, a significant interaction was
identified between APOE4 and CRF (adjusted for age and sex) in
relation to BMI. When assessed as a continuous variable, lower
fitness potentiated the influence of APOE4 on BMI (difference in
effect (significance of interaction term) p= 0.022). When CRF was
dichotomised at the median, it was found that the association
between APOE4 and lower BMI was strong in those of low fitness
(n = 142) (Mean difference = -1.78 kg/m2; 95% CI -2.74, -0.83;
p,0.001), but was absent in those of high fitness (n = 148) (Mean
difference = 0.074 kg/m2; 95% CI -0.59, 0.73; p = 0.83)
(difference in effect p= 0.002) (Table 3).
Neither PA nor fitness appears to modify APOE4 - lipid
associations
The association between APOE4 and higher TG was stronger
among those with high parent-reported PA (difference in effect
p = 0.030, adjusted for age and sex). Fitness status did not modify
the association between APOE4 (adjusted for age and sex) and
Total-C (difference in effect p = 0.84), LDL-C (p= 0.64), HDL-C
(p = 0.58), HDL/total-C ratio (p = 0.49), or TG (p= 0.30).
Association between BMI and lipids is determined by
fitness and APOE4 genotype
We also examined the associations between BMI and lipids.
Both HDL/total-C ratio (p = 0.028) and TG (p,0.001) were
significantly associated with BMI overall. When CRF was
considered as an effect modifier, it was demonstrated that these
associations were only present in those of lower CRF (adjusted for
age and sex) (BMI and HDL/total-C ratio p= 0.022; difference in
effect p = 0.034; TG p=0.001; difference in effect p = 0.038). This
suggests that the apparent lack of effect of APOE4 on BMI that is
APOE, Fitness and Adiposity in Children
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evident in children with higher fitness may be related to an
uncoupling of the relationship between BMI and blood lipids and
with greater fitness.
Further, when the fitness groups were then dichotomised by
presence or absence of APOE4, it was found that significant
associations between BMI and lipids were only evident in those
who were non-E4 and lower fitness (Table 4). It is in this same
group that BMI is significantly elevated when compared to all
other fitness/APOE4 combinations (Table 3). Thus, presence of
an APOE4 allele appears to provide protection from increased
BMI in children of low CRF, by removing the BMI-lipid
association similarly to that found in children of higher fitness
(and lower BMI). In contrast, low-fit non-E4 children tended to
have higher BMI, and a strong relationship between BMI and
lipid levels, especially a positive relationship between BMI and
TGs.
Table 1. Characteristics of the participants by ApoE genotype.
E3/E3 (n =169) E2 containing (n =39) E4 containing (n=75) p-value1
Mean SD Mean SD Mean SD
Child age 8.20 0.31 8.15 0.35 8.14 0.31 0.27
Male 73.37% (124/169) 58.97% (23/39) 26.87% (54/75) 0.20
Serum Total Cholesterol (mmol/l) 4.32 0.70 4.11 0.64 4.45 0.70 0.05
Serum LDL-cholesterol (mmol/l)l 2.63 0.64 2.26 0.50 2.75 0.66 ,0.001
Serum HDL-cholesterol (mmol/l) 1.53 0.33 1.66 0.36 1.53 0.32 0.07
Serum HDL/total cholesterol ratio 0.36 0.08 0.41 0.08 0.35 0.08 0.001
Serum triglycerides (mmol/l)* 0.66 0.56, 0.87 0.81 0.64, 1.06 0.76 0.60,0.97 0.01
Birthweight (kg) 3.17 0.80 3.14 0.76 3.05 0.80 0.55
Height (cm) 128.61 6.44 129.19 5.43 126.73 6.54 0.06
Weight (kg) 28.60 5.78 29.31 5.67 26.41 4.50 0.01
Body mass index 17.18 2.52 17.45 2.46 16.34 1.65 0.01
Waist circumference (cm) 60.67 6.75 60.76 6.48 58.33 4.90 0.02
Mid-abdominal skinfold (mm) 6.09 3.80 6.78 4.20 4.66 3.60 0.20
Suprailiac skinfold (mm) 6.03 2.53 5.66 2.87 3.44 2.80 0.03
Subscapular skinfold (mm) 7.72 4.38 7.82 4.17 6.44 1.91 0.04
Truncal fat mass (mm) 8.94 5.26 9.25 5.36 7.46 3.18 0.06
Serum insulin (mU/l) 7.31 4.80 8.01 4.21 6.16 2.72 0.06
Serum fasting glucose (mm/l) 4.47 0.47 4.46 0.38 4.44 0.45 0.87
Cardiorespiratory fitness score{ 18.47 8.96 18.49 8.11 17.68 7.56 0.79
Physical activity score{ 60.35 22.63 60.34 23.34 61.07 21.28 0.97
*Data presented as median and interquartile range.
{Cardiorespiratory fitness score (CRF) = number of laps completed in shuttle test.
{Physical activity score (PA) = number of steps/minutes pedometer worn.
1Analysis of Variance (unadjusted). x2 analysis used for sex.
doi:10.1371/journal.pone.0026679.t001
Table 2. Lipid and body size characteristics in E4-containing and Not E4-containingAPOE genotype groups.
E4 containing (n =75) Not E4-containing (n =208)
Mean SD Mean SD p-value{
Body mass index 16.34 1.65 17.23 2.50 0.004
Waist circumference (cm) 58.33 4.90 60.69 6.68 0.006
Truncal fat mass (mm) 7.46 3.18 9.00 5.27 0.02
Serum Total Cholesterol (mmol/l) 4.45 0.70 4.28 0.69 0.08
Serum LDL-cholesterol (mmol/l)l 2.75 0.66 2.56 0.63 0.03
Serum HDL-cholesterol (mmol/l) 1.53 0.32 1.56 0.34 0.58
Serum HDL/total cholesterol ratio 0.35 0.08 0.37 0.08 0.07
Serum triglycerides (mmol/l)* 0.76 0.60, 0.97 0.70 0.57, 0.92 0.37
{Linear regression (unadjusted).
*Data presented as median and interquartile range.
doi:10.1371/journal.pone.0026679.t002
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Serum insulin
Given that insulin resistance and obesity appear intrinsically
linked, we performed further analyses to consider the role of
insulin in the identified associations and interactions. None of the
observed relationships were materially altered by adjustment for
insulin. Particularly, the association of APOE4 and BMI was still
evident only in the low-fit group following adjustment for insulin
(low-fit p = 0.001; high-fit p = 0.71). Therefore, the effect of
APOE4 and fitness on BMI appeared independent of mechanisms
related to serum insulin.
Similar associations are seen for other measures of
adiposity
We performed similar analyses on truncal fat mass and waist
circumference, including association with APOE4, adjustment for
confounders, and interaction with CRF, and observed similar
associations (data not shown). Therefore, these similar relation-
ships demonstrate consistency in the pattern of findings not only
for BMI but across various measures of adiposity.
Discussion
This cohort sample incorporates a rare combination of
childhood measures, including adiposity, APOE genotype, blood
lipid profile, and PA and CRF. Using this study, we have identified
that APOE4 appears to be associated with reduced adiposity in
children. Additionally, this effect is modified by CRF; in children
of lower CRF, APOE4 seems to predispose to lower adiposity, but
also to a more atherogenic serum lipid profile. These findings show
the importance of examining APOE, adiposity and blood lipids in
the context of related PA and fitness.
There is a well-established association between APOE genotype
and blood lipids in both adults and children [2] [3,4,5,6,7]. In the
TIHS, as expected, APOE4-carrying individuals had significantly
higher LDL-C levels than those carrying other alleles. We also
observed an association between APOE genotype and adiposity.
Individuals with an APOE4-containing genotype had lower mean
BMI, truncal fat mass and waist circumference than those with
other genotypes. This suggests that the E4 allele may have a
protective effect against increased adiposity. Little evidence for a
conversely detrimental effect of E2 on adiposity was observed.
Insight into the possible mechanism(s) through which APOE
regulates fatness might be gleaned from consideration of the
regulation of lipid flux by adipocytes. Adipocytes act as storage
compartments for TGs. TGs are either produced endogenously by
adipocytes from internalised free fatty acids that are the product of
triglyceride rich lipoprotein (TGRL) breakdown in the circulation,
or from internalised TGRLs themselves, which are broken down
endogenously. In the circulation, ApoE carries TGRLs, such as
VLDLs and chylomicrons, to adipose cells, and thus ApoE
inefficiency has the capacity to reduce clearance of lipid from the
circulation into adipose tissue. EKO mice demonstrate smaller
adipocytes, and less adipose tissue [21]. Recent studies have
demonstrated that endogenous ApoE modulates the TG content
of adipocytes, independently of exogenous ApoE [1,8]. Further,
when mice with either knocked-in human APOE3, or APOE4, were
subjected to high fat diets for 8 weeks, E4 knock-ins were
significantly more resistant to obesity than E3 knock-ins [9]. Taken
Table 3. Interaction between APOE genotype and fitness in determining BMI.
BMI (kg/m2)
Fitness APOE n Mean (SD) Mean difference (95% CI)* P value
High Not E4-containing 104 16.39 (1.69)
E4-containing 34 16.44 (1.68) 0.074 (-0.59, 0.73) 0.825
Low Not E4-containing 104 18.07 (2.88)
E4-containing 41 16.25 (1.65) -1.78 (-2.74, -0.83) ,0.001
Difference in effect { 0.002
Fitness measured by shuttle test and dichotomised at the median.
*Linear regression adjusted for age and sex.
{Difference in the association between E4 and BMI by fitness category.
doi:10.1371/journal.pone.0026679.t003
Table 4. Associations between BMI and blood lipids in the low fitness group by absence (n = 104) or presence (n = 41) of an APOE4
allele.
No APOE4 allele APOE4 allele
Lipid Regression coefficient (95% CI)* P value Regression coefficient (95% CI)* P value
Total Cholesterol 0.60 (-0.19, 1.39) 0.133 -0.04 (-1.01, 0.93) 0.94
LDL-C 1.06 (0.15, 1.98) 0.023 0.22 (-0.58, 1.03) 0.58
HDL-C -1.47 (-3.20, 0.27) 0.097 -0.68 (-2.23, 0.85) 0.37
HDL/Total-C ratio -11.38 (-19.08, -3.69) 0.004 -3.46 (-10.25, 3.33) 0.31
Log triglycerides 2.55 (1.03, 4.08) 0.001 1.03 (-0.58, 2.63) 0.20
Fitness measured by shuttle test and dichotomised at the median. There were no associations between BMI and blood lipids for either of the high-fit-APOE4 genotype
combinations.
*Adjusted for age and sex.
doi:10.1371/journal.pone.0026679.t004
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together, these data suggest that a possible mechanism through
which E4 may protect against adiposity is via a reduction in the
ability of adipocytes to accumulate TG.
PA was recently demonstrated to modify the effect of obesity
related genes in adults [12]. PA has also been shown to modify the
effect of APOE genotype on lipids, particularly LDL-C, in children
and adults [7,13]. We saw little evidence of such an interaction
when considering both an objective, and a subjective measure of
PA, although the ability to fully test this was limited by the fact that
we collected objective PA data at only one time-point in a single
day. However, a novel aspect of this study was our ability to also
examine the effect of CRF on the child APOE-adiposity
association. This is of relevance because CRF appears more
important in controlling cardiovascular disease risk factors than
PA [22]. Our data concurs with recent work demonstrating that
the association between CRF and PA is generally weak [23],
especially in children [24]. It is likely that CRF is determined not
only by a number of environmental factors that includes PA, but
also by genetic factors [25]. Thus there is a clear need to consider
PA and CRF separately. We found no interaction between PA and
APOE genotype in determining BMI. However, we did find that
APOE4 was strongly associated with lower BMI only in those of
lower CRF, and had little effect on BMI in those of higher CRF.
This suggests that the mode of action through which APOE4 exerts
its apparent protective effect against adiposity may only be
relevant in those who are less fit.
We also examined the relationship between blood lipids and BMI
in children grouped by APOE variant and fitness. There was little
association between lipids and BMI, except in the low-fit, non-E4
allele group, where BMI was associated with TG, LDL-C, and
HDL/Total-C ratio. We suggest that in children of higher fitness,
lipid may be more efficiently removed from circulation via, for
example, muscle metabolism, and in those carrying APOE4, storage
of lipid by adipocytes is reduced. Only in children who are of lower
fitness and who lack APOE4 may be free to take up and store lipids
at a rate that is mainly dependent on circulating lipid levels.
The relationship between APOE4, circulating LDL-C, cardio-
vascular risk, and BMI warrants further scrutiny. It is well
established that APOE4 predisposes to higher circulating LDL-C,
along with higher cardiovascular risk [2]. In the TIHS, we
confirmed the association of E4 with higher LDL-C, however the
study design precluded assessment of cardiovascular risk. The
lower BMI seen in E4 carriers appears somewhat counterintuitive
to higher cardiovascular risk that might be predicted to be present
in these individuals. But the existence of a direct relationship
between high BMI, as one of a web of metabolic syndrome factors,
and increased cardiovascular risk, is unclear [26,27,28,29].
Barriers to the deposition of lipid into adipocytes may result in
lower BMI, but may also drive higher circulating levels of lipids
such as LDL-C and thus a more detrimental atherogenic lipid
profile and higher cardiovascular risk. Thus, it is possible that
while APOE4 might confer protection from fatness, it may also
confer higher risk of cardiovascular disease.
It is also pertinent to mention that, despite recent large scale
genome-wide association analyses [11], association of APOE
genotype with human adiposity has not, to our knowledge, been
reported previously. We suggest that this may be because genome-
wide association studies have by-and-large focussed on adult
obesity. We also suggest that the effects of APOE on adiposity may
not be strongly and replicably apparent without both specific
consideration of the E4 allele, and the interaction of E4 with CRF.
Additionally, the lack of consistency of association of APOE
genotype with various lipids such as TGs and HDL-C across
numerous studies [2,30,31,32,33] may be due to the interacting
effect of BMI and CRF, the latter of which is rarely taken into
consideration in such analyses. Our findings require independent
confirmation in cohorts where data on both APOE genotype and
CRF is available. However, we suggest our data demonstrates the
importance of the consideration of environmental factors in
tandem with genetic factors, in order to continue to progress our
understanding of the architecture of complex diseases and
phenotypes [34].
It is interesting to speculate as to whether APOE may be a
‘thrifty’ gene during times of food abundance. Thrifty genes are
historically advantageous in times of famine, but are rendered
detrimental by modern high fat diets and sedentary lifestyles [35].
In Caucasians, as in most populations, the APOE3 allele is the most
frequent, and is in high frequency in the non-APOE4-containing
genotype carriers to which we compared our E4-containing
carriers. Our data suggests that E3 (and also possibly E2) may
provide more efficient fat deposition than E4, and may be the
thrifty allele(s) that in the face of high fat diets and low fitness
levels, now predispose to higher BMI. The modern APOE4 allele
might protect against fat deposition, however it appears to also
predispose to a more atherogenic lipid profile [2], thus leading to a
higher risk of cardiovascular disease in APOE4 carriers.
In conclusion, in 8 yr old children from the TIHS, APOE4 is
associated with lower BMI. The relationship between APOE4 and
lower BMI is potentiated by lower CRF. We propose that, in those
of lower CRF, APOE4 compensates for the lack of the protective
effect of fitness from increased adiposity. Based on animal model
studies, the mechanism through which APOE4 may protect against
increased adiposity may involve a decreased ability of E4-
expressing adipocytes to take up, synthesise, and/or store TGs.
At a future clinical level, we suggest that assessment of child CRF
and APOE4 genotype may potentially define a subgroup that is
more vulnerable to increased adiposity, and therefore more at risk
of later obesity-related disease. Although our sample size is
relatively small, our data provide strong impetus for further
examination of the role of APOE in determining adiposity in larger
studies of both children and adults.
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